Universal Registration Document

Overview

The report describes 2023 as a year of clinical progress: the Kalios Optimise II study delivered positive one-year efficacy and safety results in 20 patients, while the first Epygon mitral-valve implantation was successfully performed. It also reports management strengthening through the appointments of a Chief Financial Officer and Director of Development.

Document

Report type: Annual Report
Class: Financial
Scope: Full report
Fiscal year: 2023
Period: 1 January 2023 – 31 December 2023
Publication date: 30 April 2024
Language: English
Pages
File size

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services